gene	event	source	treatment	cancerType	doid	level	direction	urls
ALK	FUSION	VICC_CGI	Crizotinib	Lung Adenocarcinoma	X	A	RESPONSIVE	http
BRCA1	INACTIVATION	ICLUSION	DRUP	Solid Tumors	X	B	RESPONSIVE	http
ERBB2	AMPLIFICATION	VICC_CIVIC	Trastuzumab	Breast Cancer	X	A	RESPONSIVE	http
ERBB2	AMPLIFICATION	VICC_CIVIC	Panitumumab	Colorectal Cancer	X	B	RESISTANT	http,https
FGFR2	FUSION	VICC_CGI	Erdafitinib	Bladder Cancer	X	B	RESPONSIVE	http
MET	AMPLIFICATION	ICLUSION	DRUP	Solid Tumors	X	B	RESPONSIVE
NRAS	ACTIVATION	VICC_CGI	Cetuximab	Colorectal Cancer	X	A	RESISTANT	http